October 2018 – Expanding the Impact of Substance Use Disorder Research: Economic Analysis for Program and Policy Evaluation
March 2018 – Conducting Health Economic Analyses Alongside CTN Trials
For those attending the National Drug Abuse Treatment Clinical Trials Network Annual Scientific and Steering Committee Meetings held March 20 – 22, 2018 in North Bethesda, MD, CHERISH held a “Conducting Health Economic Analyses Alongside CTN Trials” half-day workshop on March 20, 2018. Presenters included CHERISH leaders Bruce Schackman, Kathryn McCollister, and Sean Murphy as well as Patricia Novo, MPA, MPH of New York University’s School of Medicine, and Katharine Bradley, MD, MPH of Kaiser Permanente Washington Health Research Institute.
In this workshop health economists and clinical trialists involved with traditional and newer trial designs shared their experiences working together in three phases of conducting economic analyses alongside CTN trials: pre-trial planning, data collection, and data analysis.
March 2018 – Introduction to Economic Evaluation
The “Introduction to Economic Evaluation” training was held on March 19, 2018 in North Bethesda, MD at the Bethesda North Marriott Hotel & Conference Center. The training was targeted to trainees and investigators in the substance use disorder, HCV, and HIV fields interested in learning about health economic evaluation to integrate into their own research. The course provided an introduction to multiple economic evaluation methods used to evaluate health care services, with a focus on substance use disorders, HIV, and HCV, as well as exposure to measurement of cost, health utilities and quality-adjusted life years (QALYs); cost-effectiveness analysis; and cost-benefit analysis.
August 2017 – Introduction to Economic Evaluation in Substance Use Disorders
CALDAR Program Course Description Watch the Course
June 2017 – New Insights Into the Economics of Substance Use Disorder Treatment: Addressing the Opioid Epidemic
CHERISH Director Dr. Bruce Schackman, Methodology Core Co-Director Dr. Kathryn McCollister, and Consultation Service Director Dr. Sean Murphy held a Pre-Congress session entitled “New Insights Into the Economics of Substance Use Disorder Treatment: Addressing the Opioid Epidemic” on Saturday, July 8th, 2017 from 1:30PM to 5:00PM. The session discussed evolving methods in economic evaluation of substance use disorders (SUD) in response to the recently released recommendation of the Second Panel on Cost Effectiveness in Health and Medicine. They also presented findings from applied studies of the economic impact of interventions for opioid use disorders. The session was structured to promote interactive discussion to identify new high priority areas for health economics research relating to substance use disorders.
December 2016 – Introduction to Economic Evaluation in Substance Use Disorder, HCV, and HIV Treatments
This training was targeted at investigators in the substance use disorder, HCV, and HIV fields interested in learning about health economic evaluation to integrate into their own research. The course provided an introduction to multiple economic evaluation methods used to evaluate health care services, with a focus on substance use disorders, HIV and HCV. The course provided participants with a more in-depth exposure to cost-effectiveness analysis; introducing students to concepts of decision analysis, measurement of cost, health utilities and quality adjusted lift years (QALYs). Students also received a briefer introduction to cost-benefit analysis, budget impact analysis, and simulation modeling techniques. All training was held in New York City on the campus of Weill Cornell Medicine with Days 1 and 2 in the Belfer Research Building at 413 East 69th Street Day 3 at 1300 York Avenue. All days began at 8:00 AM and ended by 6:00 PM.